Real World Outcomes of Older Adults and Frail Patients with Relapse/Refractory Multiple Myeloma Receiving Idecabtagene Vicleucel
Study #: MM23-01b
Study Status: Published
Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study.
Akhtar OS, Oloyede T, Brazauskas R, Afrough A, Hashmi H, Sidana S, Ahmed N, Bye M, Hansen DK, Ferreri CJ, Dhakal B, Dhanda DS, Harrison MJ, Kitali A, Landau HJ, Mirza A, Patel J, Patwardhan P, Qazilbash MH, Patel KK, Nishihori T, Ganguly S, Gowda L, Anderson LD, Pasquini MC, Usmani SZ, Freeman CL.
Blood Advances. 2024, Dec 30: (): . doi: 10.1182/bloodadvances.2024014970. Epub 2024, Dec 30. PMCID:.
PMID: 39786391
Abstract